Evidence map›Paper›PMID 31533639›Full record

ArticleBMC infectious diseases2019

Rapid development of HIV elite control in a patient with acute infection.

Deirdre Morley, John S Lambert, Louise E Hogan, Cillian De Gascun, Niamh Redmond, Rachel L Rutishauser, Cassandra Thanh, Erica A Gibson, Kristen Hobbs, Sonia Bakkour and 4 more

Erratum issuedAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Deirdre MorleyMater Misericordae University Hospital, Eccles Street, Dublin, 7, Ireland. deemorley@gmail.com.ORCID http://orcid.org/0000-0002-8572-7481
John S LambertMater Misericordae University Hospital, Eccles Street, Dublin, 7, Ireland.
Louise E HoganDepartment of Medicine, University of California San Francisco Division of Experimental Medicine, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.
Cillian De GascunNational Virus Reference Laboratory, University College Dublin, Dublin, Ireland.
Niamh RedmondUCD Clinical Research Centre, Dublin, Ireland.
Rachel L RutishauserDepartment of Medicine, University of California San Francisco Division of Experimental Medicine, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.
Cassandra ThanhDepartment of Medicine, University of California San Francisco Division of Experimental Medicine, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.
Erica A GibsonDepartment of Medicine, University of California San Francisco Division of Experimental Medicine, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.
Kristen HobbsDepartment of Medicine, University of California San Francisco Division of Experimental Medicine, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.
Sonia BakkourVitalant Research Institute, 270 Masonic Ave, San Francisco, CA, 94118, USA.
Michael P BuschVitalant Research Institute, 270 Masonic Ave, San Francisco, CA, 94118, USA.
Jeremy FarrellMater Misericordae University Hospital, Eccles Street, Dublin, 7, Ireland.
Padraig McGetrickMater Misericordae University Hospital, Eccles Street, Dublin, 7, Ireland.
Timothy J HenrichDepartment of Medicine, University of California San Francisco Division of Experimental Medicine, 1001 Potrero Avenue, San Francisco, CA, 94110, USA.

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
NIAID NIH HHS P30 AI027763
6 · The paper itself

Abstract

backgroundElite controllers (EC), a small subset of the HIV-positive population (< 1%), suppress HIV viremia below the limit of quantification of clinical viral load assays in the absence of antiretroviral therapy (ART). However, there is a paucity of longitudinal data detailing the viral and immune dynamics or HIV reservoir seeding during acute infection in individuals that go on to become Elite Controllers. CASE PRESENTATION: In this report, we describe a case of a 42 year old woman diagnosed during acute infection who rapidly and permanently suppressed her viremia in the absence of antiretroviral therapy (ART). Rapid antibody/antigen testing was either negative or equivocal during acute infection, despite subsequent viral load testing at that time point with 71,550 plasma HIV RNA copies/mL, making initial diagnosis challenging. The patient subsequently developed detectable anti-HIV antibodies and an increase in HIV-specific CD8+ T cell responses to overlapping subtype C HIV gag peptide; very low-level plasma viremia (0.84 RNA copies/mL) was detected by an ultrasensitive assay 2 years following infection. Subsequently, she was started on ART for multifocal furunculosis despite continued suppression of virus and stable CD4+ T cell counts. Following ART initiation, HIV specific antibody levels and CD8+ T cell responses increased, but no HIV DNA or RNA was able to be isolated from large numbers of peripheral blood CD4+ T cells.

conclusionThis case provides important information regarding the establishment of elite HIV control during acute infection and also demonstrates an increase in HIV-specific immune responses following ART despite undetectable peripheral blood cellular measures of HIV persistence. This case also highlights the challenges in diagnosing acute HIV infection without the use of viral load testing in this rare elite controller phenotype.

Indexed as

AdultAnti-Retroviral AgentsCD4 Lymphocyte CountCD8-Positive T-LymphocytesFemaleHIV-1HIV AntibodiesHIV InfectionsHumansRNA, ViralViral LoadAnti-Retroviral AgentsHIV AntibodiesRNA, ViralAcute HIV infectionAntiretroviral therapyElite controlHIV-1HIV immune responsesHIV reservoirs

Identifiers

PMID31533639
PMCPMC6749690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.